These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 380492)

  • 21. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.
    Shapiro E; Shapiro AK; Fulop G; Hubbard M; Mandeli J; Nordlie J; Phillips RA
    Arch Gen Psychiatry; 1989 Aug; 46(8):722-30. PubMed ID: 2665687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
    Sallee FR; Nesbitt L; Jackson C; Sine L; Sethuraman G
    Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ningdong granule on DA, DRD2, and HVA in a rat model of Tourette's syndrome.
    Lv H; Lin HY; Zhao H; Li AY; Lin Y; Yao B
    J Tradit Chin Med; 2012 Jun; 32(2):283-8. PubMed ID: 22876458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gilles de la Tourette's disease].
    Gonge M; Barbeau A
    Union Med Can; 1977 Apr; 106(4):559-70. PubMed ID: 324070
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial incidence of Gilles de la Tourette's disease, with observations on aetiology and treatment.
    Friel PB
    Br J Psychiatry; 1973 Jun; 122(571):655-8. PubMed ID: 4146056
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of familial exhibitionism in Tourette's syndrome successfully treated with haloperidol.
    Comings DE; Comings BG
    Am J Psychiatry; 1982 Jul; 139(7):913-5. PubMed ID: 6953768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity and variability in Tourette syndrome.
    Caine ED; Polinsky RJ; Ludlow CL; Ebert MH; Nee LE
    Adv Neurol; 1982; 35():437-42. PubMed ID: 6959522
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of gastrodin on the dopamine system of Tourette's syndrome rat models.
    Lv H; Li A; Liu F; Ma H; Yao B
    Biosci Trends; 2009 Apr; 3(2):58-62. PubMed ID: 20103948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol therapy in Tourette's syndrome: neurophysiological, biochemical and behavioral correlates.
    Messiha FS; Knopp W; Vanecko S; O'Brien V; Corson SA
    Life Sci I; 1971 Apr; 10(8):449-57. PubMed ID: 5280506
    [No Abstract]   [Full Text] [Related]  

  • 34. Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms.
    Arnold LE; Wender PH; McCloskey K; Snyder SH
    Arch Gen Psychiatry; 1972 Dec; 27(6):816-22. PubMed ID: 4564954
    [No Abstract]   [Full Text] [Related]  

  • 35. Schizophrenic symptoms improve with apomorphine.
    Tamminga CA; Schaffer MH; Smith RC; Davis JM
    Science; 1978 May; 200(4341):567-8. PubMed ID: 347574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of piribedil and of d-amphetamine on locomotor activity in immature rats.
    Dourish CT; Cooper SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):249-55. PubMed ID: 6539932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphetamine and piribedil in affective illness.
    Post RM; Jimerson DC; Silberman EK
    Psychopharmacol Bull; 1980 Jan; 16(1):57-9. PubMed ID: 6987695
    [No Abstract]   [Full Text] [Related]  

  • 38. Catecholamine metabolism in Gilles de la Tourette's syndrome.
    Lake CR; Ziegler MG; Eldridge R; Murphy DL
    Am J Psychiatry; 1977 Mar; 134(3):257-60. PubMed ID: 265141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An objective evaluation of haloperidol in Gilles de la Tourette's syndrome.
    Ford CV; Gottlieb F
    Dis Nerv Syst; 1969 May; 30(5):328-32. PubMed ID: 4890446
    [No Abstract]   [Full Text] [Related]  

  • 40. Nifedipine-haloperidol combination in the treatment of Gilles de la Tourette's syndrome: a case study.
    Alessi NE; Walden M; Hsieh PS
    J Clin Psychiatry; 1989 Mar; 50(3):103-4. PubMed ID: 2925592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.